HUMAN-B CELL INTERLEUKIN-10

被引:43
|
作者
BENJAMIN, D
PARK, CD
SHARMA, V
机构
[1] Division of Hematology and Oncology, The Arthur G. James Cancer Hospital and Research Institute, Comprehensive Cancer Center, The Ohio State University, Columbus, OH
关键词
INTERLEUKIN-10; AIDS; LYMPHOKINE; BCRF1; LYMPHOMA;
D O I
10.3109/10428199409059591
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interleukin 10 (IL-10) is a novel lymphokine which exhibits strong DNA and amino-acid sequence homology to BCRF1, an open reading frame in the Epstein-Barr virus genome. Using a wide panel of EBV positive and EBV negative cell lines, it has been shown that EBV positive B cell lines derived from patients with AIDS and Burkitt's lymphoma (AABCL) secrete large quantities of B cell IL-10, compared-with EBV-positive B cell lines obtained from patients with undifferentiated lymphomas of Burkitt's and non-Burkitt's types. In contrast, EBV-negative B cell lines do not express IL-10 by Northern blot analysis, ELISA or even PCR. B cell IL-10 is confined to a narrow window in the B cell differentiation pathway, and whereas IL-10 expression is detected in mature and preplasmacytic stages, none of the pro-B, pre-B, or myeloma cell lines produce IL-10. EBV exerts direct effect on the production of B cell IL-10, and purified tonsillar B cells infected with EBV were triggered to secrete IL-10. The large amount of IL-10 secreted by B cells derived from AIDS-related lymphomas suggests that HIV-1 also exerts direct effect on IL-10 secretion. B cell IL-10 may function as autocrine growth factor for B cell lymphomas, and both IL-10 and BCRFI seem to be involved in the pathophysiology of non-Hodgkin's lymphomas.
引用
收藏
页码:205 / 210
页数:6
相关论文
共 50 条
  • [1] INTERLEUKIN-10 IN HUMAN B-CELL DIFFERENTIATION
    LI, L
    XIA, X
    CHOI, YS
    FASEB JOURNAL, 1994, 8 (04): : A256 - A256
  • [2] A review of the association between interleukin-10 and human B-cell malignancies
    Vijay P. Khatri
    Michael A. Caligiuri
    Cancer Immunology, Immunotherapy, 1998, 46 : 239 - 244
  • [3] A review of the association between interleukin-10 and human B-cell malignancies
    Khatri, VP
    Caligiuri, MA
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 46 (05) : 239 - 244
  • [4] Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation
    Chang, Chun-Chun
    Liu, Cheng-Der
    Pan, Sheng-Feng
    Huang, Wei-Han
    Peng, Chih-Wen
    Hsu, Hao-Jen
    TZU CHI MEDICAL JOURNAL, 2020, 32 (03): : 245 - 253
  • [5] Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes
    Iannone, F
    De Bari, C
    Dell'Accio, F
    Covelli, M
    Cantatore, FP
    Patella, V
    Lo Bianco, G
    Lapadula, G
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (02) : 139 - 146
  • [6] Interleukin-10 and the interleukin-10 receptor
    Moore, KW
    Malefyt, RD
    Coffman, RL
    O'Garra, A
    ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 : 683 - 765
  • [7] Interleukin-10 stabilizes inhibitory κB-α in human monocytes
    Shames, BD
    Selzman, CH
    Meldrum, DR
    Pulido, EJ
    Barton, HA
    Meng, XZ
    Harken, AH
    McIntyre, RC
    SHOCK, 1998, 10 (06): : 389 - 394
  • [8] REGULATION OF HUMAN MICROGLIAL CELL RELEASE OF INTERLEUKIN-10 BY CYTOKINES
    SHENG, WS
    HU, SX
    PETERSON, PK
    CHAO, CC
    FASEB JOURNAL, 1995, 9 (04): : A824 - A824
  • [9] DIFFERENTIAL EXPRESSION OF VIRAL AND HUMAN INTERLEUKIN-10 (IL-10) BY PRIMARY B-CELL TUMORS AND B-CELL LINES
    STEWART, JP
    BEHM, FG
    ARRAND, JR
    ROONEY, CM
    VIROLOGY, 1994, 200 (02) : 724 - 732
  • [10] Nuclease activity of human interleukin-10
    Dranitsyna, SM
    Kostanyan, IA
    Astapova, MV
    Surina, EA
    Lipkin, VM
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2002, 28 (01) : 74 - 76